Welcome to Wopular's coverage of Drugmaker, Sanofi-aventis.
Wopular aggregates news headlines from the top newspapers and
news sources. To the right are articles about
Drugmaker, Sanofi-aventis that have been featured on main sections
of the site.
Below are topics about Drugmaker, Sanofi-aventis. (Click on "all"
to view all articles related to the topic, including articles NOT about
Drugmaker, Sanofi-aventis.
French drugmaker Sanofi-Aventis launched a hostile bid for Genzyme at $69 per share on Monday, taking its $18.5 billion offer direct to shareholders after Genzyme management refused to negotiate.